Elutia, Inc. (ELUT)
0.8392
+0.02
(+2.34%)
USD |
NASDAQ |
Nov 16, 13:48
Elutia EPS Diluted (Quarterly) : -0.1468 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.1468 |
| June 30, 2026 | -0.1729 |
| March 31, 2026 | -0.1836 |
| December 31, 2025 | -0.1283 |
| September 30, 2025 | -0.1909 |
| June 30, 2025 | -0.2557 |
| March 31, 2025 | -0.2128 |
| December 31, 2024 | -0.26 |
| September 30, 2024 | -0.3309 |
| June 30, 2024 | -1.132 |
| March 31, 2024 | -0.7525 |
| December 31, 2023 | -0.6603 |
| September 30, 2023 | -0.5728 |
| June 30, 2023 | -0.6546 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.4938 |
| December 31, 2022 | -0.376 |
| September 30, 2022 | -0.7254 |
| June 30, 2022 | -0.69 |
| March 31, 2022 | -0.6003 |
| December 31, 2021 | -0.8179 |
| September 30, 2021 | -0.8125 |
| June 30, 2021 | -0.2332 |
| March 31, 2021 | -0.4955 |
| December 31, 2020 | -0.5238 |
| September 30, 2020 | -0.9601 |
| June 30, 2020 | -0.5064 |
| March 31, 2020 | -0.4275 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 0.0183 |
| Amgen, Inc. | 7.077 |
| Anika Therapeutics, Inc. | -0.0232 |
| BioCryst Pharmaceuticals, Inc. | 0.1417 |
| Imunon, Inc. | -0.6412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.503M |
| Revenue (Quarterly) | 1.137M |
| Total Expenses (Quarterly) | 7.64M |
| Enterprise Value | 23.34M |
| Gross Profit Margin (Quarterly) | 61.74% |
| Profit Margin (Quarterly) | -571.9% |
| Earnings Yield | -75.26% |
| Normalized Earnings Yield | -67.25 |